Summary of Study ST002625

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001020. The data can be accessed directly via it's Project DOI: 10.21228/M8V97D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002625
Study TitleMoTrPAC: Endurance exercise training study in young adult rats, Tissue:White Adipose - Targeted Nucleotides
Study SummaryThe goal of the endurance exercise training study in young adult rats (internal code: PASS1B-06) was to perform exercise training studies in adult (6 month) F344 rats, and from these rats collect as many tissues as feasible in order to provide high quality samples for detailed analysis by chemical analysis sites. Tissues were collected from 10-12 rats sedentary control rats concurrent with the collection of the 8-week training groups. The 8-week training group and controls were from the same cohort and same age at euthanasia (either 8). For the older age group, an additional set of controls (n=5-6) were collected with the 1-2 week training group. Rats were either sedentary or underwent an exercise training program. Rats were exercised on the rodent treadmill 5 days per week using a progressive training protocol designed to exercise the rats at approximately 70% of VO2max as outlined in the Table on the next page. Training was performed no earlier than 10:00 am and no later than 5:00 pm over 5 consecutive days per week. Training was initiated with the treadmill set at 70% of VO2 max (see tables) and 5 degrees grade for 20 minutes. The duration of exercise was increased by one minute each day until day 31 of training (start of week 7), when a duration of 50 min was reached. Speed and grade of each training session increased in larger increments due to treadmill parameters. The highest intensity and duration of training began on day 31. This intensity was maintained for the final 10 days of the protocol to ensure steady state had been achieved. If any rats were unable to perform at least 4 days of training per week they were removed from the study and euthanized. It is important to note that the starting treadmill speed varied depending on the sex and age of the rat. The initial and maximum speeds were based on VO2max measurements obtained during the pre-training testing of the compliant rats. Rats assigned to the control group followed a schedule similar to the training group. They were placed in one lane on the treadmill for 15 minutes/day, 5 days per week. The treadmill was set at 0 m/min at an incline that corresponded to the incline being used by the training group.
Institute
Duke University
DepartmentDuke Molecular Physiology Institute
LaboratoryMetabolomics Core Laboratory
Last NameNewgard
First NameChristopher
Address300 N Duke St, Durham, NC 27701
Emailchris.newgard@duke.edu
Phone(919) 668-6059
Submit Date2023-04-25
Raw Data AvailableYes
Raw Data File Type(s)TBD
Analysis Type DetailLC-MS
Release Date2023-10-06
Release Version1
Christopher Newgard Christopher Newgard
https://dx.doi.org/10.21228/M8V97D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001020
Project DOI:doi: 10.21228/M8V97D
Project Title:MoTrPAC
Project Summary:MoTrPAC is a national research consortium designed to discover and perform preliminary characterization of the range of molecular transducers (the "molecular map") that underlie the effects of physical activity in humans. The program's goal is to study the molecular changes that occur during and after exercise and ultimately to advance the understanding of how physical activity improves and preserves health. Preclinical and clinical studies will examine the systemic effects of endurance and resistance exercise across a range of ages and fitness levels by molecular probing of multiple tissues before and after acute and chronic exercise. This program is the largest targeted NIH investment of funds into the mechanisms of how physical activity improves health and prevents disease. The MoTrPAC program is supported by the NIH Common Fund and is managed by a trans-agency working group representing multiple NIH institutes and centers, led by the NIH Office of Strategic Coordination, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, and National Institute of Biomedical Imaging and Bioengineering. MoTrPAC Steering Committee: Wendy Kohrt, Chair, Russ Tracy, Co-Chair; NIH Program Manager, Concepcion Nierras. Euan Ashley and Matthew Wheeler are the PIs for the Motrpac Bioinformatics / Data Coordination Center.
Institute:MoTrPAC
Last Name:Ashley
First Name:Euan
Address:Falk Building CV267, 870 Quarry Road, Stanford, California 94305
Email:motrpac-data-deposition@lists.stanford.edu
Phone:(650) 725-1846

Subject:

Subject ID:SU002727
Subject Type:Mammal
Subject Species:Rattus norvegicus
Taxonomy ID:10116

Factors:

Subject type: Mammal; Subject species: Rattus norvegicus (Factor headings shown in green)

mb_sample_id local_sample_id Group Timepoint Sex
SA26150790245017012Control 8 weeks of training or control time Female
SA26150890248017012Control 8 weeks of training or control time Female
SA26150990252017012Control 8 weeks of training or control time Female
SA26151090266017012Control 8 weeks of training or control time Female
SA26151190265017012Control 8 weeks of training or control time Female
SA26151290232017012Control 8 weeks of training or control time Male
SA26151390217017012Control 8 weeks of training or control time Male
SA26151490229017012Control 8 weeks of training or control time Male
SA26151590239017012Control 8 weeks of training or control time Male
SA26151690237017012Control 8 weeks of training or control time Male
SA26151780012817002_3QC-ExternalStandard 0 hour -
SA26151880013827002_2QC-ExternalStandard 0 hour -
SA26151980013827002_3QC-ExternalStandard 0 hour -
SA26152080012817002_1QC-ExternalStandard 0 hour -
SA26152180012817002_2QC-ExternalStandard 0 hour -
SA26152280013827002_4QC-ExternalStandard 0 hour -
SA26152380012817002_4QC-ExternalStandard 0 hour -
SA26152480013827002_1QC-ExternalStandard 0 hour -
SA26152590571017012Training 1 week of training or control time Female
SA26152690564017012Training 1 week of training or control time Female
SA26152790567017012Training 1 week of training or control time Female
SA26152890560017012Training 1 week of training or control time Female
SA26152990559017012Training 1 week of training or control time Female
SA26153090430017012Training 1 week of training or control time Male
SA26153190423017012Training 1 week of training or control time Male
SA26153290422017012Training 1 week of training or control time Male
SA26153390421017012Training 1 week of training or control time Male
SA26153490426017012Training 1 week of training or control time Male
SA26153590576017012Training 2 weeks of training Female
SA26153690585017012Training 2 weeks of training Female
SA26153790578017012Training 2 weeks of training Female
SA26153890587017012Training 2 weeks of training Female
SA26153990581017012Training 2 weeks of training Female
SA26154090441017012Training 2 weeks of training Male
SA26154190449017012Training 2 weeks of training Male
SA26154290450017012Training 2 weeks of training Male
SA26154390439017012Training 2 weeks of training Male
SA26154490444017012Training 2 weeks of training Male
SA26154590410017012Training 4 weeks of training Female
SA26154690420017012Training 4 weeks of training Female
SA26154790416017012Training 4 weeks of training Female
SA26154890406017012Training 4 weeks of training Female
SA26154990412017012Training 4 weeks of training Female
SA26155090280017012Training 4 weeks of training Male
SA26155190289017012Training 4 weeks of training Male
SA26155290281017012Training 4 weeks of training Male
SA26155390283017012Training 4 weeks of training Male
SA26155490292017012Training 4 weeks of training Male
SA26155590258017012Training 8 weeks of training or control time Female
SA26155690259017012Training 8 weeks of training or control time Female
SA26155790251017012Training 8 weeks of training or control time Female
SA26155890254017012Training 8 weeks of training or control time Female
SA26155990267017012Training 8 weeks of training or control time Female
SA26156090222017012Training 8 weeks of training or control time Male
SA26156190218017012Training 8 weeks of training or control time Male
SA26156290223017012Training 8 weeks of training or control time Male
SA26156390225017012Training 8 weeks of training or control time Male
SA26156490227017012Training 8 weeks of training or control time Male
Showing results 1 to 58 of 58

Collection:

Collection ID:CO002720
Collection Summary:-
Sample Type:White adipose

Treatment:

Treatment ID:TR002736
Treatment Summary:-

Sample Preparation:

Sampleprep ID:SP002733
Sampleprep Summary:Nucleotides are extracted from 200”l of tissue homogenates prepared at 50 mg /ml in methanol using hexane. The extracts are dried under nitrogen and reconstituted in water.
Sampleprep Protocol Filename:pass1b_experimental_design_metabolomics.pdf

Combined analysis:

Analysis ID AN004297
Analysis type MS
Chromatography type Reversed phase
Chromatography system Waters Acquity UPLC
Column Chromolith FastGradient RP-18e 50-2mm column (EMD Millipore, Billerica, MA, USA)
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Waters Xevo TQ-XS
Ion Mode NEGATIVE
Units pmol/mg of tissue

Chromatography:

Chromatography ID:CH003203
Chromatography Summary:Injection volume is 2 ”L. Mobile phase A is 95% water, 5% methanol and 5 mM dimethylhexylamine adjusted to pH 7.5 with acetic acid. Mobile phase B is 20% water, 80% methanol and 10 mM dimethylhexylamine. Flow rate is set to 0.3 mL/min and column temperature is 40 °C. A 22 min gradient method (t=0, %B=0; t=1.2, %B=0; t=22, %B=40) is run followed by a 3 min wash and 7 min equilibration.
Methods Filename:pass1b_nuc_methods.pdf
Instrument Name:Waters Acquity UPLC
Column Name:Chromolith FastGradient RP-18e 50-2mm column (EMD Millipore, Billerica, MA, USA)
Column Temperature:40C
Flow Gradient:22-minute gradient (t=0, %B=0; t=1.2, %B=0; t=22, %B=40) followed by a 3-minute wash and 7-minute equilibration
Flow Rate:0.3 ml/min
Solvent A:95% water/5% methanol; 5 mM dimethylhexylamine adjusted to pH 7.5 with acetic acid
Solvent B:20% water/80% methanol; 10 mM dimethylhexylamine
Chromatography Type:Reversed phase

MS:

MS ID:MS004044
Analysis ID:AN004297
Instrument Name:Waters Xevo TQ-XS
Instrument Type:Triple quadrupole
MS Type:ESI
MS Comments:All nucleotides were detected in negative ion MRM mode based on a characteristic fragmentation reaction.
Ion Mode:NEGATIVE
  logo